We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$433M
AUM Growth
+$33.6M
Cap. Flow
+$30.1M
Cap. Flow %
6.97%
Top 10 Hldgs %
35.53%
Holding
194
New
33
Increased
45
Reduced
29
Closed
6

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$10.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.48M
3
PE
PARSLEY ENERGY INC
PE
+$4.25M
4
CELG
Celgene Corp
CELG
+$3.67M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.26M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$743K
2
AAPL icon
Apple
AAPL
+$533K
3
GE icon
GE Aerospace
GE
+$437K
4
GS icon
Goldman Sachs
GS
+$424K
5
MMM icon
3M
MMM
+$187K

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Financials 16.86%
3 Technology 16.26%
4 Energy 11.68%
5 Consumer Staples 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROST icon
51
Ross Stores
ROST
$81.7B
$811K 0.19%
14,300
– –
PFE icon
52
Pfizer
PFE
$154B
$775K 0.18%
23,192
+1,078
+5% +$34.4K
EW icon
53
Edwards Lifesciences
EW
$53B
$658K 0.15%
19,800
– –
JPM icon
54
JPMorgan Chase
JPM
$956B
$656K 0.15%
10,550
+1,850
+21% +$116K
APD icon
55
Air Products & Chemicals
APD
$68.6B
$625K 0.14%
4,756
– –
CVS icon
56
CVS Health
CVS
$122B
$579K 0.13%
6,043
+155
+3% +$15.4K
SWNC
57
DELISTED
Southwestern Energy Company
SWNC
$577K 0.13%
19,175
+800
+4% +$23.2K
SNN icon
58
Smith & Nephew
SNN
$12.6B
$561K 0.13%
16,350
– –
MITT.PRA
59
TPG Mortgage Investment Trust 8.25% Series A Preferred Stock
MITT.PRA
$44.1M
$554K 0.13%
22,000
– –
VRSN icon
60
VeriSign
VRSN
$26.5B
$532K 0.12%
6,153
– –
SCHW
61
Charles Schwab
SCHW
$188B
$528K 0.12%
20,857
+3,000
+17% +$85.3K
MSFT icon
62
Microsoft
MSFT
$3.76T
$509K 0.12%
9,938
– –
SI
63
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$469K 0.11%
4,600
– –
ETP
64
DELISTED
Energy Transfer Partners L.p.
ETP
$438K 0.1%
11,525
– –
CYS.PRB
65
DELISTED
CYS Investments, Inc.
CYS.PRB
$435K 0.1%
+18,500
New +$434K
LMT icon
66
Lockheed Martin
LMT
$139B
$419K 0.1%
1,690
+90
+6% +$21.2K
OXY icon
67
Occidental Petroleum
OXY
$58.6B
$419K 0.1%
5,550
+50
+0.9% +$3.74K
SRE icon
68
Sempra
SRE
$55.1B
$367K 0.08%
6,448
-1,200
-16% -$63.6K
ORCL icon
69
Oracle
ORCL
$435B
$360K 0.08%
8,800
– –
ABT icon
70
Abbott
ABT
$188B
$352K 0.08%
8,960
– –
AVY icon
71
Avery Dennison
AVY
$13.5B
$351K 0.08%
4,700
-500
-10% -$37.1K
RTX icon
72
RTX Corp
RTX
$302B
$334K 0.08%
5,169
-318
-6% -$20.4K
GIS icon
73
General Mills
GIS
$19.9B
$328K 0.08%
4,600
– –
BP icon
74
BP
BP
$110B
$324K 0.07%
10,874
– –
KMB icon
75
Kimberly-Clark
KMB
$35.9B
$319K 0.07%
2,322
– –
1 2
3
4 5

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Kelly Lawrence W & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Kelly Lawrence W & Associates held 194 positions worth $433M, up 8.4% from $399M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Kelly Lawrence W & Associates deployed $30.1M of net new capital in Q2 2016, opening 33 new positions and adding to 45 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was American International, an estimated $743K trimmed.

  • Kelly Lawrence W & Associates's largest Q2 2016 buy was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.
  • Kelly Lawrence W & Associates added most to Allergan plc in Q2 2016, an estimated $10.3M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2016 reduction was American International, cutting an estimated $743K.
  • Kelly Lawrence W & Associates fully exited Marsh in Q2 2016, selling an estimated $103K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 36% of its $433M portfolio in Q2 2016.
  • Kelly Lawrence W & Associates opened 33 new positions and closed 6 in Q2 2016.
  • Kelly Lawrence W & Associates's portfolio value rose 8.4% quarter-over-quarter to $433M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.